TB Status | Total (n = 149) | Male to female ratio M;F | Age, years (Median) | TLC (10 e3/L) | Lymphocyte count (%) |
|---|
QFT Positive (n = 56) |
Active TB | (n = 33) |
PTB | 10 | 3:7 | 44 | 7.9 | 17.25 |
EPTB | 23 | 8:15 | 44 | 7.85 | 24.1 |
Latent TB | 23 | 17:6 | 50 | 8.5 | 22.05 |
QFT Negative | (n = 93) |
Active TB | (n = 20) | | | | |
PTB | 3 | 0:3 | 18 | 7 | 27.8 |
EPTB | 17 | 9:8 | 45 | 9.4 | 17.2 |
Non TB | 73 | 35:38 | 54 | 8.5 | 21.3 |
- ‘TLC’, total lymphocytes count; ‘QFT’, Quantiferon-Gold in Tube assay (Cellestis, Germany); ‘PTB’, pulmonary TB; ‘EPTB’, extrapulmonary TB (lymph node, abdominal, TB meningitis, tuberculoma, pelvic, pleural, thyroid, knee and spine). ‘M:F’, male: female; ‘Active TB’, subjects with a confirmed TB diagnosis based on positive radiology, microbiology, microscopy testing and/or a positive treatment response; ‘Probable ‘Latent TB’ cases were QFT-G positive without a confirmed diagnosis of TB; ‘Non-TB’, cases were QFT-G negative and without a confirmed diagnosis of TB. Cut-off for QFT positive ≥0.35 IU/ml. Lymphopenia is defined as lymphocytes < 1500 cells/mm3. Data is presented as Median values
